The PAN Foundation signs MAPRx Coalition letter to the Centers for Medicare and Medicaid Services

Given the increasing use and increasing costs of specialty drugs, beneficiaries are being forced to bear a greater share of expenses.

We believe that the high OOP trends from 2019 are not an anomaly; it is an example of the increasing burden of prescription costs shouldered by beneficiaries. Therefore, we welcome any attention CMS places on this issue.